1-240092470-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020066.5(FMN2):c.361C>A(p.Leu121Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000423 in 1,609,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020066.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FMN2 | NM_020066.5 | c.361C>A | p.Leu121Ile | missense_variant | 1/18 | ENST00000319653.14 | NP_064450.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FMN2 | ENST00000319653.14 | c.361C>A | p.Leu121Ile | missense_variant | 1/18 | 5 | NM_020066.5 | ENSP00000318884 | P1 | |
FMN2 | ENST00000447095.5 | c.-87+24397C>A | intron_variant | 3 | ENSP00000409308 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152088Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000439 AC: 64AN: 1456966Hom.: 0 Cov.: 89 AF XY: 0.0000387 AC XY: 28AN XY: 724438
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152088Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74276
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.361C>A (p.L121I) alteration is located in exon 1 (coding exon 1) of the FMN2 gene. This alteration results from a C to A substitution at nucleotide position 361, causing the leucine (L) at amino acid position 121 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at